Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Liver
»
Neoplasms
30. July 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3851
Articles 1 - 20 / 77013
Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.
PLoS One
Gu K, Kang TW, Shin J, Sinn DH, Goh MJ, Hong JY, Chi S.
PMID: 42520023 [PubMed - indexed for MEDLINE]
Neoadjuvant therapy for hepatocellular carcinoma: emerging combinations and biomarker challenges.
Front Immunol
Palihati S, Mo H, Ye X, Yi C, Liang X.
PMID: 42519345 [PubMed - indexed for MEDLINE]
Economic value of finotonlimab plus bevacizumab versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma in China and the United States.
Front Public Health
He Y, Jiang Q, Pan X, Deng L, Hu X, Yang Z, Lang W.
PMID: 42518569 [PubMed - indexed for MEDLINE]
Effects of Sevoflurane on the Proliferation, Migration, and Xenograft Growth of HepG2 Hepatocellular Carcinoma Cells: An Exploratory In Vitro and In Vivo Study.
Medicina (Kaunas)
Kim KS, Kim Y, Shin K, Paing AS, Baek S, Hong B, Lim C.
PMID: 42512809 [PubMed - indexed for MEDLINE]
Clinical and Genetic Determinants of Hepatocellular Carcinoma in a Turkish Cohort: Impact of SLCO1B1 and SLCO1B3 Germline Variations and Demographic Risk Factors.
Int J Mol Sci
Altintas Z.
PMID: 42511559 [PubMed - indexed for MEDLINE]
Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation.
Int J Mol Sci
Mu X, Meng W, Zheng L.
PMID: 42511550 [PubMed - indexed for MEDLINE]
Genome-Wide Association Studies in Hepatocellular Carcinoma: Aetiology-Specific Susceptibility, Functional Interpretation, and Clinical Translation.
Genes (Basel)
Zhang S, Long X.
PMID: 42510799 [PubMed - indexed for MEDLINE]
Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options.
Curr Oncol
Kang NK, Lee SJ, Kang HJ, Shin HJ, Kwon JH, Lee SK, Kim M.
PMID: 42505227 [PubMed - indexed for MEDLINE]
Where does histotripsy fit into hepatocellular carcinoma care?
Cancer
Lau-Min KS, Wang J.
PMID: 42504148 [PubMed - indexed for MEDLINE]
[Primary hepatic actinomycosis mimicking a malignant liver tumor: Case report and review of the Latin American literature].
Rev Gastroenterol Peru
Cubas-Garcia D, Sanchez-Zavaleta J, Román-Hernández G, Kapsoli-Sanchez MDC, Urbina-Rojas N.
PMID: 42501997 [PubMed - indexed for MEDLINE]
Preoperative MRI Intratumoral Heterogeneity Radiomics for Microvascular Invasion and Recurrence-Free Survival in HCC.
Liver Int
Liu R, Xie Y, Yue L, Jia J, Wang L, Liao J, Li HW, Yao H, Zhang J, Wang Y, Zhou X, Shi W, Ma J, Chen Q, Ma X, Zhou W, Yang L, Ning G, Zhou Y, Hu P, Li F, Zhuo L.
PMID: 42500825 [PubMed - indexed for MEDLINE]
Colorectal cancer liver metastases: mechanism and therapy.
Front Immunol
Liu S, Ban L, Zhang W, Sun Y, Wang K, Man Y, Zhang Y.
PMID: 42500682 [PubMed - indexed for MEDLINE]
Integrative Analysis Identified an Eight-Gene Risk Signature Linked to CDK7 and Explored Its Association with HCC Progression via RelA Phosphorylation.
Oncol Res
Lan B, Tan J, Wang Q, Zeng S.
PMID: 42500561 [PubMed - indexed for MEDLINE]
Financial toxicity profiles and their associations with healthcare utilization and catastrophic health expenditure in patients with primary liver cancer.
Medicine (Baltimore)
Li H, Yang L, Zhao L, Wang W, Mei H.
PMID: 42499025 [PubMed - indexed for MEDLINE]
Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.
Liver Int
Calvo-Sánchez H, Jara-Fernández L, Encijo-Heredia R, Villarino I, Alvarado R, Quiñones-Calvo M, Gutiérrez ML, Miquel J, Torralba M, Catalá M, Gómez J, Albertos S, Barquero-Pérez Ó, Fernández-Rodríguez C, Larrubia JR.
PMID: 42499017 [PubMed - indexed for MEDLINE]
Small nucleolar RNA host genes in hepatocellular carcinoma: an evidence-weighted and etiology-aware framework for mechanistic and translational interpretation.
Mol Biol Rep
El-Sehrawy AAMA, Ahmed YK, Djumayeva N, Mohammed JS, Almas A, Jabir MS, Hussien S, Smerat A, Shakir MN, Basunduwah TS.
PMID: 42496957 [PubMed - indexed for MEDLINE]
Macroscopic fractal dynamics characterize the "physical-metabolic" dual barriers and systemic immune exhaustion associated with primary resistance to immunotherapy in liver metastases.
Front Immunol
Guo Z, Guo C, Lu Z, Zou K, Zhang H.
PMID: 42495635 [PubMed - indexed for MEDLINE]
Hepatoid Adenocarcinoma of the Stomach with Liver Metastasis Misdiagnosed as Hepatocellular Carcinoma: A Case Report and Literature Review.
Ann Clin Lab Sci
Zhu YY, Zhao JR, Xu CL, Wu LP, Wu ZY.
PMID: 42492970 [PubMed - indexed for MEDLINE]
The Prognostic Impact of the Number of Colorectal Liver Metastases At the Time of Presentation Among Patients Undergoing Surgery.
J Gastrointest Cancer
Murakami H, Matsumura M, Kuno Y, Okada T, Okubo S, Hashimoto M, Shindoh J.
PMID: 42489965 [PubMed - indexed for MEDLINE]
Cholesterol metabolic rewiring shapes immune remodeling across hepatocarcinogenesis.
Front Immunol
Ma W, Yan F, Cheng Y, Zhang G, Mu Y, Zhang Z, Liang X, Gan J, Yang W, Zhu W, Cheng Y.
PMID: 42488674 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 77013
Page 1 of 3851
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy